Current Liabilities

Lease Liability Payments - Due Year Four

Neurocrine Biosciences Lease Liability Payments - Due Year Four increased by 0.5% to $60.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $60.80M to $60.70M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026

How to read this metric

Consistent growth in these payments may indicate expansion of physical footprint or equipment fleet.

Detailed definition

The projected cash payments for operating and finance leases scheduled for the fourth year following the balance sheet d...

Peer comparison

Standard disclosure for lease maturity profiles.

Metric ID: lease_liability_payments_due_year_4

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$15.50M$15.50M$15.70M$15.70M$15.70M$16.00M$16.00M$16.00M$35.60M$36.60M$36.60M$60.80M$60.80M$60.40M$60.70M
QoQ Change+0.0%+1.3%+0.0%+0.0%+1.9%+0.0%+0.0%+122.5%+2.8%+0.0%+66.1%+0.0%-0.7%+0.5%
YoY Change+1.3%+1.3%+1.9%+1.9%+1.9%+122.5%+128.8%+128.8%+70.8%+66.1%+65.0%-0.2%
Range$15.50M$60.80M
CAGR+47.7%
Avg YoY Growth+49.2%
Median YoY Growth+33.5%

Lease Liability Payments - Due Year Four at Other Companies

Frequently Asked Questions

What is Neurocrine Biosciences's lease liability payments - due year four?
Neurocrine Biosciences (NBIX) reported lease liability payments - due year four of $60.70M in Q1 2026.
How has Neurocrine Biosciences's lease liability payments - due year four changed year-over-year?
Neurocrine Biosciences's lease liability payments - due year four decreased by 0.2% year-over-year, from $60.80M to $60.70M.
What does lease liability payments - due year four mean?
The total lease payments due in the fourth year from now.